Quick summary of my question:
Our organization is transitioning to Epic/Beaker for the main LIS and SafeTrace TX for the Blood Bank module. I understand that Beaker does not have FDA 510K clearance as a Blood Bank LIS, so we can't do "Blood Bank tests" there. However, does anyone have any resources on what is defined as "Blood Bank" when evaluating what can go into Beaker? In specific terms, do you think having Beaker built to automatically calculate the volume of a fetal bleed based on a Kleihauer-Betke stain is acceptable? What about automatically calculating the dose of Rh Immune Globulin (RhIg) should the patient be Rh negative?
Longer version of the story:
In our lab, Hematology / Manual Bench does the Kleihauer-Betke (KLEI) testing, and it has historically been resulted as a % / ML result only. Then, it gets handed off to Blood Bank where we answered a separate test code with the RhIg dosing comments with EVERY SINGLE KLEI, even when there is no RhIg ordered or when the mom is Rh positive. It's always felt a bit unnecessary to have Blood Bank result a separate test every single time, and the idea was proposed to have Beaker automatically calculate the RhIg dose based on calculations built into Result Entry. Then, the KLEI would go out with the mL of the bleed, and a comment:
"If patient is Rh negative and Rh Immune Globulin is needed, then a ___ ug dose is recommended. Enter a Transfuse Rh Immune Globulin order if Rh Immune Globulin is to be administered."
In this workflow, if a RhIg order is received after the fact (or before), Blood Bank staff would verify the appropriateness of the request, and review the KLEI for dosing requirements, then send the order to Pharmacy for fulfillment. I'm wondering if this is acceptable practice. I could reach out to the FDA as well if no one has a resource here, but hoping someone else has had the same idea!
Thanks,
Susan